You are here: Industry Insights > Denmark

News List

Denmark suspends AZ/Oxford Covid-19 vaccination amid blood clot concerns pharmaceutical-technology
March 12, 2021
The Danish National Board of Health has temporarily paused the roll-out of the AstraZeneca/Oxford Covid-19 vaccine.
Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark contractpharma
March 08, 2021
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, held a virtual ground-breaking ceremony to celebrate the start of its large-scale cell culture expansion ...
Novo Nordisk invests in facility expansion at production site in Denmark pharmatimes
February 26, 2021
Novo Nordisk will invest DKK 500 million (£57.96m) to expand facilities at an existing production site in Måløv, Denmark.
Investors angry about insulin woes sue Novo Nordisk in Denmark for $1.75B fiercepharma
August 18, 2019
Novo’s been relying less on insulins for growth these days as its GLP-1 franchise steams ahead. But trouble in its insulin franchise still lingers—and now it'll have to defend against a group of investors who sued in Denmark, claiming it made “misleading”
Fujifilm Completes Acquisition of Biogen’s Manufacturing Site in Denmark contractpharma
August 05, 2019
Invests roughly $890 million in project.
USA struggles and middle income countries could do more in tackling health inequality according to Oxfam report pharmafile
November 20, 2018
A cluster of Latin American countries such as Costa Rica, Uruguay and Argentina, and a cluster of OECD countries with long-term commitments to public investment
Novo Nordisk to lay off 400 employees in Denmark and China pharmaceutical-technology
September 25, 2018
Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy.
Novo Nordisk to lay off 400 employees in Denmark and China pharmaceutical-technology
September 21, 2018
Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy.
AGC Biologics increases manufacturing capacity at Denmark biospectrum
September 10, 2018
The addition of this proprietary bioreactor configuration will enable more flexible, innovative, and customized cGMP production capabilities, offering scales from 2000 L to 12000 L within a single run
endpoint selected as sole IRT provider for Ferring Pharmaceuticals AS pharmaasia
February 06, 2017
endpoint has been selected as the sole IRT provider for Ferring Pharmaceuticals AS, a biopharmaceutical company based in Denmark.